Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Brain Pathology (Zurich, Switzerland)|February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastomaJoanna J Phillips, Derick Aranda, David W Ellison, et al.
Oncotarget|December 10, 2015
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma riskKyle M Walsh, Veryan Codd, Terri Rice, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
Neuro-Oncology|January 2, 2024
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect groupPhilipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.
Neuro-Oncology Advances|November 3, 2022
<i>TERT</i> promotor status does not add prognostic information in <i>IDH</i>-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO <i>resect</i> groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Brain Pathology (Zurich, Switzerland)|February 27, 2013
PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastomaJoanna J Phillips, Derick Aranda, David W Ellison, et al.
Oncotarget|December 10, 2015
Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma riskKyle M Walsh, Veryan Codd, Terri Rice, et al.
Neuro-Oncology|September 27, 2023
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomasAtsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, et al.
The Journal of Clinical Investigation|December 9, 2021
Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomasHirokazu Ogino, Jennie W Taylor, Takahide Nejo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Neuro-Oncology|June 5, 2013
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesisKyle M Walsh, Terri Rice, Paul A Decker, et al.
Neuro-Oncology|January 2, 2024
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect groupPhilipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|August 12, 2022
Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.
Neuro-Oncology Advances|November 3, 2022
<i>TERT</i> promotor status does not add prognostic information in <i>IDH</i>-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO <i>resect</i> groupPhilipp Karschnia, Jacob S Young, Antonio Dono, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Pageof 21